Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2012
10/17/2012CN102210650B Prednicarbate emulsifiable paste and preparation method thereof
10/17/2012CN102144986B Potassium chloride cyclopenthiazide sustained release tablet and preparation method thereof
10/17/2012CN102133405B Preparation method and application of liposome-chitosan compound gene carrier
10/17/2012CN102114246B Amphiphilic polysaccharide derivative vector for specific medicine release in organism focusas well as preparation and application of pharmaceutical composition thereof
10/17/2012CN102106810B Medicinal solid composition containing cephalosporin antibiotics and preparation method thereof
10/17/2012CN102058518B Self-expandable microgel pulse preparation with layer-by-layer assembled polyelectrolytes and preparation method thereof
10/17/2012CN102048685B Pefloxacin mesylate injection and preparation method and application thereof
10/17/2012CN102002117B Branched chitosan derivative and preparation method thereof
10/17/2012CN101991629B Glaucescent fissistigma root saponin composition and preparation method thereof
10/17/2012CN101983667B Shiqi exogenous traditional Chinese medicine beverage
10/17/2012CN101972470B In-situ gel composition for eyes
10/17/2012CN101967195B Thrombolysis-targeting fusion protein mAnxB1ScuPA, structure and application thereof
10/17/2012CN101951956B Drug delivery system for administration of poorly water soluble pharmaceutically active substances
10/17/2012CN101948507B Novel anti-cancer medicaments using NGR(NO2) as targeting carrier, preparation thereof and use thereof
10/17/2012CN101919801B Solid effervescent mixture for oral absorption
10/17/2012CN101854954B A methods for preparing the clathrate compound of steroid medicines utilizing hydrotalcite as carrier
10/17/2012CN101791408B Cationic polymer gene vector having low cytotoxicity and high transfection efficiency, preparation method and use thereof
10/17/2012CN101605548B Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection
10/17/2012CN101548958B Dispersing tablet containing terbinafine hydrochloride
10/17/2012CN101536988B Troxerutin freeze-dried powder injection and preparation method thereof
10/17/2012CN101502494B Bromhexine hydrochloride freeze-dried injection and preparation method thereof
10/17/2012CN101480451B Prescription for treating upper respiratory tract infection and use thereof
10/17/2012CN101294008B Filler, process for producing the same, and cosmetic
10/17/2012CN101287470B Improved testosterone gel and method of use
10/17/2012CN101175512B Medical composition for promotion of skin regeneration
10/16/2012US8288590 N-substituted monomers and polymers
10/16/2012US8288351 Antagonists of the bradykinin B1 receptor
10/16/2012US8287907 Dissolution composition for examining drug solubility
10/16/2012US8287904 Stable soft capsule dosage form for acetylsalicylic acid
10/16/2012US8287898 Compositions and methods for body weight management
10/16/2012US8287897 Bitterness-masking particulate jelly beverage
10/16/2012US8287894 Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease
10/16/2012US8287879 Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
10/16/2012US8287877 Composition comprising immunogenic microparticles
10/16/2012US8287850 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012US8287848 Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
10/16/2012US8287847 Administering potassium binding polymer of alpha-fluoroacrylic acid comprising counterion of calcium crosslinked with divinylbenzene, (m)ethylenebisacrylamide, N,N'-bis(vinylsulfonylacetyl) ethylene diamine, 1,3-bis(vinylsulfonyl) 2-propanol, vinylsulfone, polyvinyl ether, polyallylether; hyperkalemia
10/16/2012US8287846 Cosmetic or dermatological preparations comprising N-acetylcysteine
10/16/2012CA2723823C Conjugates for the treatment of mesothelioma
10/16/2012CA2714757C Low viscosity liquid polymeric delivery system
10/16/2012CA2685230C Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
10/16/2012CA2648594C Solid oral dosage form containing an enhancer
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2597740C Modified-release preparations containing oxcarbazepine and derivatives thereof
10/16/2012CA2538619C Re-targeted toxin conjugates
10/16/2012CA2530136C In-situ gelling drug delivery system
10/16/2012CA2516028C Conjugates comprising a cancer targeting molecule linked to a liver-expressed chemokine
10/16/2012CA2505040C Composition for iontophoretic delivery of rotigotine
10/16/2012CA2471906C A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity
10/16/2012CA2451847C A novel engineered superantigen for human therapy
10/16/2012CA2446781C Coated granules based on angiotensin-converting enzyme inhibitor
10/16/2012CA2443069C Synthesis and use of glycodendrimer reagents
10/16/2012CA2439763C Pharmaceutical compositions based on anticholinergics and pde-iv inhibitors
10/16/2012CA2250970C Cyclosporin emulsions
10/16/2012CA2223427C Collagen-based delivery matrix
10/11/2012WO2012139112A1 Ubiquitin fusions for improving the efficacy of cytosolic acting targeted toxins
10/11/2012WO2012139097A2 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/11/2012WO2012139094A2 Method of developing a vaccine using peptide-poly ic complexes
10/11/2012WO2012138529A1 Novel polysaccharide derivatives and dosage forms
10/11/2012WO2012138467A1 Photostabilization of resveratrol with alkoxycrylene compounds
10/11/2012WO2012138441A1 Composition and method for topical treatment of skin lesions
10/11/2012WO2012138341A1 Controlled delivery of molecules from a biointerface
10/11/2012WO2012138246A1 Pharmaceutical composition for treating hyperproliferative diseases
10/11/2012WO2012137999A1 High-sensitivity magnetic resonance imaging nano-contrast agent based on an anionic polymer and cationic polymer ion complex, and a production method therefor
10/11/2012WO2012137967A1 Calcium phosphate microcapsule
10/11/2012WO2012137932A1 Composition for external application
10/11/2012WO2012137834A1 Method for producing endoplasmic reticulum
10/11/2012WO2012137610A1 Pharmaceutical preparation
10/11/2012WO2012137150A2 Cell penetrating peptides for intracellular delivery of molecules
10/11/2012WO2012137054A1 Pharmaceutical composition containing cyclobenzaprine suitable to intranasal administration
10/11/2012WO2012137036A1 Cell penetrating peptides for intracellular delivery of molecules
10/11/2012WO2012136829A1 Novel combination treatment of cancer
10/11/2012WO2012136816A2 Pharmaceutical composition
10/11/2012WO2012136790A1 Compositions comprising fusion proteins or conjugates with an improved half -life
10/11/2012WO2012136638A1 Sugar and peg functionalized polyacetals with controlled ph-dependent degradation
10/11/2012WO2012136369A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma
10/11/2012WO2012136309A1 Melanocyte-stimulation hormone for suppressing inflammation reactions in hemodialysis
10/11/2012WO2012136125A1 Compound dual-release capsule formulation comprised of bromodihydroartemisinin and a fe2+ agent
10/11/2012WO2012106118A3 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings
10/11/2012WO2012105797A3 Structure having nanoantenna and method for manufacturing same
10/11/2012WO2012085171A3 Pharmaceutical compositions of pyridinium and quinolinium derivatives
10/11/2012WO2012074588A3 Shear controlled release for stenotic lesions and thrombolytic therapies
10/11/2012US20120259318 Solvent/polymer solutions as suspension vehicles
10/11/2012US20120259252 Coupling Emulsions for Use With Ultrasound Devices
10/11/2012US20120259107 Coupling Low-Molecular Substances To A Modified Polysaccharide
10/11/2012US20120259023 Novel plant gum-modified food starch conjugate as emulsifying agent for fat soluble ingredients
10/11/2012US20120259022 Pharmaceutical compositions providing enhanced drug concentrations
10/11/2012US20120259021 Self-assembled particles from zwitterionic polymers and related methods
10/11/2012US20120258942 Device for transdermal administration of drugs including acrylic polymers
10/11/2012US20120258939 Pharmaceutical manufacturing process
10/11/2012US20120258911 Phenylalkylcarboxylic acid delivery agents
10/11/2012US20120258169 Chewable Soft Capsule
10/11/2012US20120258165 Phospholipid derivative and ph-responsive liposomes
10/11/2012US20120258150 Particles comprising volatile materials and particle gas saturated solution processes for making same
10/11/2012US20120258106 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
10/11/2012US20120258069 Rgd-binding compounds and methods of use
10/11/2012US20120258068 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof
10/11/2012US20120258059 Cosmetic, external skin preparation, and medical instrument
10/11/2012US20120258057 Silicone organic elastomer gels from organopolysiloxane resins
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 1712